Johnson & Johnson recently agreed to a tentative settlement in a Connecticut talcum powder asbestos cancer lawsuit brought by a plaintiff who claims he developed cancer as a result of decades of using talc-based products produced by the company. The settlement is a rare move on the part of the pharmaceutical and cosmetics giant, which has taken the position to aggressively fight asbestos cancer lawsuits alleging its talcum powder products were the cause of various forms of cancer, including mesothelioma.
According to the talcum powder asbestos cancer lawsuit, filed in Superior Court of Bridgeport, the plaintiff claims he developed mesothelioma cancer as a result of exposure to asbestos fibers in Johnson & Johnson’s Baby Powder. The mesothelioma cancer lawsuit also named other defendants that manufactured or sold products contaminated with asbestos which were contributing factors in his mesothelioma diagnosis.
Johnson & Johnson had previously attempted to have itself removed from the lawsuit and its part of the case remanded to a federal court after its long-time talc supplier Imerys Talc USA and co-defendant in the case filed for bankruptcy. That action, which has been a strategy of Johnson & Johnson to remove itself from state courts, was unsuccessful, and the company was forced to remain enjoined with the other defendants named in the lawsuit.